Hepcidin in anemia and inflammation in chronic kidney disease

被引：78

作者：

Malyszko, Jolanta ^{[1
]}

Mysliwiec, Michal ^{[1
]}

机构：

[1] Med Univ Bialystok, Dept Nephrol & Transplantol, PL-15540 Bialystok, Poland

来源：

KIDNEY & BLOOD PRESSURE RESEARCH | 2007年 / 30卷 / 01期

关键词：

hepcidin; anemia; inflammation; chronic kidney disease; iron balance; regulation; dialysis patients; anemia and iron balance;

D O I：

10.1159/000098522

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

Maintaining the correct iron balance is crucial for health. Our understanding of the molecular control of iron metabolism has increased dramatically over the past 5 years due to the discovery of hepcidin. This is a circulating antimicrobial peptide mainly synthesized in the liver, which has been recently proposed as a factor regulating the uptake of dietary iron and its mobilization from macrophages and hepatic stores. Inflammation causes an increase of production of hepcidin, which is a potent mediator of anemia of chronic diseases. Anemia in chronic kidney disease is mainly due to erythropoietin deficiency but these patients often have a chronic inflammatory state. The aim of this review is to summarize the current knowledge dealing with a possible role of hepcidin in iron metabolism and its regulation, particularly in kidney disease. In addition, current methods of determination of hepcidin are reviewed. Copyright (c) 2007 S. Karger AG, Basel.

引用

页码：15 / 30

页数：16

共 112 条

[41] Diferric transferrin regulates transferrin receptor 2 protein stability [J].

Johnson, MB ;

Enns, CA .

BLOOD, 2004, 104 (13) :4287-4293

[42] Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice [J].

Katsume, A ;

Saito, H ;

Yamada, Y ;

Yorozu, K ;

Ueda, O ;

Akamatsu, K ;

Nishimoto, N ;

Kishimoto, T ;

Yoshizaki, K ;

Ohsugi, Y .

CYTOKINE, 2002, 20 (06) :304-311

[43] Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells [J].

Kawabata, H ;

Nakamaki, T ;

Ikonomi, P ;

Smith, RD ;

Germain, RS ;

Koeffler, HP .

BLOOD, 2001, 98 (09) :2714-2719

[44] Novel urine hepcidin assay by mass spectrometry [J].

Kemna, E ;

Tjalsma, H ;

Laarakkers, C ;

Nemeth, E ;

Willems, H ;

Swinkels, D .

BLOOD, 2005, 106 (09) :3268-3270

[45] Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS [J].

Kemna, E ;

Pickkers, P ;

Nemeth, E ;

van der Hoeven, H ;

Swinkels, D .

BLOOD, 2005, 106 (05) :1864-1866

[46] LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity [J].

Krause, A ;

Neitz, S ;

Mägert, HJ ;

Schulz, A ;

Forssmann, WG ;

Schulz-Knappe, P ;

Adermann, K .

FEBS LETTERS, 2000, 480 (2-3) :147-150

[47] Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia [J].

Kulaksiz, H ;

Gehrke, SG ;

Janetzko, A ;

Rost, D ;

Bruckner, T ;

Kallinowski, B ;

Stremmel, W .

GUT, 2004, 53 (05) :735-743

[48] The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney [J].

Kulaksiz, H ;

Theilig, F ;

Bachmann, S ;

Gehrke, SG ;

Rost, D ;

Janetzko, A ;

Cetin, Y ;

Stremmel, W .

JOURNAL OF ENDOCRINOLOGY, 2005, 184 (02) :361-370

[49] THE PHENOMENON OF THE ACUTE PHASE RESPONSE [J].

KUSHNER, I .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 389 (JUN) :39-48

[50] Effect of hepcidin on intestinal iron absorption in mice [J].

Laftah, AH ;

Ramesh, B ;

Simpson, RJ ;

Solanky, N ;

Bahram, S ;

Schümann, K ;

Debnam, ES ;

Srai, SKS .

BLOOD, 2004, 103 (10) :3940-3944

← 1 2 3 4 5 6 7 8 9 10 →